BioSuperior is a biotherapeutics company that develops technologies to cure lung disease and repair lung tissue.
BioSuperior has raised $256K in total funding. The most recent round was Grant. The last funding was announced in June 2022.
BioSuperior's investors include National Science Foundation.
BioSuperior is headquartered in Los Altos, United States.
BioSuperior is a biotherapeutics company that develops technologies to cure lung disease and repair lung tissue.
BioSuperior is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioSuperior — Funding & Investors." VCBacked, June 17, 2022, https://www.vcbacked.co/company/biosuperior. Accessed November 12, 2026.
VCBacked. (2022). BioSuperior — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/biosuperior
{{cite web |title=BioSuperior — Funding & Investors |url=https://www.vcbacked.co/company/biosuperior |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at BioSuperior? Request a listing update